Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2022 Apr 4;69(6):e29695. doi: 10.1002/pbc.29695

Table 1:

Patient demographics and clinical course

Indication Block and Catheter %Change in opioid use# Catheter duration Opioid related adverse events Multimodal adjuncts for pain management Admission duration  
Case 1
16y F with HbSS (wt: 60kg)
Left upper extremity pain (AVN of left humeral head) Left Supraclavicular nerve block catheter −78.7% 2 days Constipation
Sedation
pruritis
Ketorolac
Ketamine
Acetaminophen
Lidocaine patch
6 days  
Case 2
13y M with HbSS (wt: 59kg)
Left shoulder pain (history of AVN) Left interscalene nerve block catheter −47.5% 2 days Constipation
Sedation
Ketorolac/Ibuprofen
Acetaminophen
Lidocaine patch
Methocarbamol
10 days  
Case 3
11y M with HbS/β0 (wt: 59kg)
Right upper extremity pain (AVN of right humeral head) Right interscalene nerve block catheter −79.6% 2 days Constipation Ketorolac/Ibuprofen
Ketamine
Acetaminophen
Lidocaine Patch
Methocarbamol
Gabapentin
Diclofenac gel
12 days  

AVN = avascular necrosis.

#

percent change in opioid use, comparing 24 hours prior to block and 24 hours after block. (%change)= [(pre-block use)-(post-block use)]/(pre-block use)*100%